VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 634 filers reported holding VANECK VECTORS ETF TR in Q3 2022. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,976,755 | -30.2% | 482,228 | -21.9% | 4.56% | -27.3% |
| Q2 2023 | $18,599,790 | -21.0% | 617,728 | -15.2% | 6.27% | -33.6% |
| Q1 2023 | $23,558,176 | -26.1% | 728,228 | -34.6% | 9.44% | -24.8% |
| Q4 2022 | $31,890,784 | +89.2% | 1,112,728 | +59.2% | 12.55% | +70.0% |
| Q3 2022 | $16,856,000 | +0.8% | 698,828 | +14.4% | 7.38% | +9.8% |
| Q2 2022 | $16,719,000 | -54.2% | 610,628 | -35.8% | 6.72% | -46.5% |
| Q1 2022 | $36,491,000 | +122.2% | 951,528 | +85.6% | 12.58% | +81.5% |
| Q4 2021 | $16,419,000 | +8.7% | 512,628 | 0.0% | 6.93% | -2.9% |
| Q3 2021 | $15,107,000 | -31.1% | 512,628 | -20.6% | 7.14% | -15.5% |
| Q2 2021 | $21,925,000 | +14.8% | 645,228 | +9.8% | 8.45% | +2.2% |
| Q1 2021 | $19,094,000 | -23.2% | 587,528 | -14.9% | 8.26% | -24.1% |
| Q4 2020 | $24,855,000 | -13.0% | 690,028 | -5.4% | 10.89% | -17.8% |
| Q3 2020 | $28,553,000 | +23.1% | 729,128 | +15.3% | 13.25% | +25.3% |
| Q2 2020 | $23,190,000 | +41.1% | 632,228 | -11.4% | 10.57% | +34.0% |
| Q1 2020 | $16,435,000 | -19.3% | 713,344 | +2.6% | 7.89% | +27.2% |
| Q4 2019 | $20,356,000 | +9.6% | 695,244 | 0.0% | 6.21% | +54.7% |
| Q3 2019 | $18,571,000 | -7.7% | 695,244 | -11.7% | 4.01% | +1.6% |
| Q2 2019 | $20,127,000 | +78.8% | 787,444 | +56.9% | 3.95% | +40.9% |
| Q1 2019 | $11,254,000 | +18.1% | 501,995 | +11.1% | 2.80% | +7.2% |
| Q4 2018 | $9,530,000 | +13.9% | 451,855 | 0.0% | 2.62% | +58.2% |
| Q3 2018 | $8,368,000 | -17.0% | 451,855 | 0.0% | 1.65% | -11.5% |
| Q2 2018 | $10,081,000 | +1.5% | 451,855 | 0.0% | 1.87% | -2.0% |
| Q1 2018 | $9,932,000 | -5.4% | 451,855 | 0.0% | 1.91% | -19.8% |
| Q4 2017 | $10,501,000 | +1.2% | 451,855 | 0.0% | 2.38% | -15.0% |
| Q3 2017 | $10,375,000 | +9.8% | 451,855 | +5.6% | 2.80% | +1.0% |
| Q2 2017 | $9,448,000 | -59.3% | 427,895 | -12.4% | 2.77% | -54.2% |
| Q1 2017 | $23,221,000 | +83.3% | 488,395 | -19.3% | 6.05% | +118.9% |
| Q4 2016 | $12,665,000 | -32.5% | 605,395 | -14.7% | 2.76% | -31.0% |
| Q3 2016 | $18,759,000 | +72.8% | 709,795 | +81.2% | 4.01% | +74.3% |
| Q2 2016 | $10,854,000 | – | 391,695 | – | 2.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |